Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07346833

Role of Circulating MicroRNAs in Differentiating Psychological Disorders Among Women With Chronic Toxoplasmosis

Deciphering The Role of Circulating MicroRNAs To Differentiate Psychological Disorders Among Women With Chronic Toxoplasmosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
Benha University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Chronic Toxoplasma gondii (T. gondii) infection is a widespread condition that can negatively affect brain function and is considered a risk factor for various psychiatric conditions, including depression and schizophrenia. This prospective observational study aims to investigate the expression levels of specific circulating microRNAs (miRNAs) in women diagnosed with schizophrenia, major depressive disorder, or bipolar disorder who also have chronic toxoplasmosis. By comparing these levels to patients without the infection, the study seeks to determine if these miRNAs can serve as biological markers to help differentiate between specific psychological disorders and identify the impact of chronic toxoplasmosis on mental health.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCirculating miRNA Expression and T. gondii SerologySerology: ELISA testing to detect anti-Toxoplasma IgG (confirming chronic infection) and IgM (excluding acute infection). Genetic Analysis: Quantitative Reverse-transcriptase PCR (qRT-PCR) to measure the expression levels of a predetermined panel of plasma miRNAs. Psychiatric Evaluation: Clinical diagnosis according to DSM-5 criteria.

Timeline

Start date
2025-11-20
Primary completion
2026-02-01
Completion
2026-04-01
First posted
2026-01-16
Last updated
2026-01-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07346833. Inclusion in this directory is not an endorsement.